Freenome Holdings

Freenome is a biotechnology company developing accurate, accessible, and non-invasive disease screening products for proactive treatment during the most manageable stages of cancer and other diseases. The company is working on a simple blood test to detect early-stage cancer, making treatment more effective, and providing a platform to help design a health profile based on an individual’s cell-free genome. The company aims to redefine disease management through systematic early detection and intervention.